The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Me Too Drugs Market, valued at USD 384.81 Million in 2024, is projected to experience a CAGR of 5.87% to reach USD 541.86 Million by 2030. 'Me Too' drugs, also recognized as follow-on or in...
November 2025
185 pages
Nuclear Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Institutional and Commercial), By Purpose (Diagnostic and Therapeutic), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Nuclear Pharmacy Market, valued at USD 5.99 Billion in 2024, is projected to experience a CAGR of 7.92% to reach USD 9.46 Billion by 2030. Nuclear pharmacy involves the preparation and disp...
November 2025
185 pages
Beyond The Pill Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Asthma, Others), By Offerings (Services, Monitoring, Assistance, Information, Education), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Beyond The Pill Market will grow from USD 282.44 Million in 2024 to USD 416.44 Million by 2030 at a 6.69% CAGR. The 'Global Beyond The Pill Market' encompasses innovative digital health sol...
November 2025
185 pages
Infantile Spasm Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Class (Anticonvulsants, Corticosteroids, Others), By Drug Type (Vigabatrin, Adrenocorticotropic Hormone, Others (Phase III)), By Dosage (Solid, Liquid), by Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Infantile Spasm Therapeutics Market , valued at USD 3.32 Billion in 2024, is projected to experience a CAGR of 4.04% to reach USD 4.21 Billion by 2030. Infantile spasm therapeutics comprise...
November 2025
182 pages
Precision Dosing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Patient Type (Pediatrics, Geriatrics, Patients on Polypharmacy, Patients with End Organ Dysfunction, Others), By Tools (Physiologically-Based Pharmacokinetic (PBPK) Modeling and Non-Linear Mixed Effects (NLME) Modeling), By Software (Web-Based and Desktop-Based), By Drug Class (Antibiotics, Antimycotics, Immunosuppressives, Antiepileptics, Antitumoral Drugs, Antidepressants, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Precision Dosing Market, valued at USD 188.34 Million in 2024, is projected to experience a CAGR of 7.72% to reach USD 294.33 Million by 2030. Precision dosing involves the accurate and con...
November 2025
185 pages
Bleeding Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Bleeding Disorders Drugs Market, valued at USD 6.03 Billion in 2024, is projected to experience a CAGR of 6.78% to reach USD 8.94 Billion by 2030. Bleeding disorders drugs are pharmaceutica...
November 2025
185 pages
Lysosomal Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Mucopolysaccharidosis, Pompes Syndrome, Fabry Diseases, Gaucher's Disease, Other), By Therapy (Substrate Reduction Therapy, Stem Cell Therapy, Enzyme Replacement Therapy, Other), By Route Of Administration (Oral, Parenteral, Other), By End User (Hospitals, Specialty Clinics, Homecare, Other), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Lysosomal Disease Treatment Market, valued at USD 8.10 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 12.22 Billion by 2030. The Global Lysosomal Disease Treatment...
November 2025
185 pages
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anti-Viral Drugs Market, valued at USD 77.10 Billion in 2024, is projected to experience a CAGR of 3.89% to reach USD 96.94 Billion by 2030. Antiviral drugs are pharmaceutical agents develo...
November 2025
181 pages
Monkeypox Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Smallpox Vaccine, Antivirals, Vaccinia Immune Globulin (VIG)), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Monkeypox Therapeutics Market, valued at USD 87.00 Million in 2024, is projected to experience a CAGR of 9.01% to reach USD 145.99 Million by 2030. Monkeypox therapeutics encompass pharmace...
November 2025
185 pages
Antifibrinolytic Drugs Market - 2026-2032
US$ 3,400.00
Antifibrinolytic Drugs Market reached US$ 16.93 Billion in 2024 and is expected to reach US$ 24.51 Billion by 2033, growing with a CAGR of 4.20% during the forecast period 2026-2033. The Antifibrinoly...
November 2025
48 pages
Hirschsprung Disease Treatment Market - 2024-2031
US$ 3,400.00
Hirschsprung Disease Treatment Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Hirschsprung Disease Treatment Market emerges as a key focus in DataM Intelligence lat...
November 2025
56 pages
Bloom Syndrome Treatment Market - 2024-2031
US$ 3,400.00
Bloom Syndrome Treatment Marketis is growing with a CAGR of 4.50% during the forecast period 2026-2035. The Bloom Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-depth...
November 2025
50 pages
Urinary Incontinence Therapeutics Market Size, Share & Trends Analysis Report By Type (Stress Incontinence, Urge Incontinence), By Drug Class, By Gender, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global urinary incontinence therapeutics market size was estimated at USD 4.32 billion in 2024 and is projected to reach USD 6.95 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033. This...
November 2025
150 pages
U.S. Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Product (Viscosupplements, Platelet-Rich Plasma Therapy, Adipose Tissue Therapy, Bone Graft Substitutes), By Application, By Primary User, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. osteoarthritis therapeutics market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 4.50 billion by 2033, growing at a CAGR of 8.61% from 2025 to 2033. Growing ger...
November 2025
190 pages
Non-alcoholic Steatohepatitis Treatment Market - 2025-2031
US$ 3,400.00
Non-alcoholic Steatohepatitis Treatment Marketis is growing with a CAGR of 54.00% during the forecast period 2026-2035. The Non-alcoholic Steatohepatitis Treatment Market emerges as a key focus in Dat...
November 2025
65 pages
Global Oral Diuretic Drugs Market Growth 2025-2031
US$ 3,660.00
The global Oral Diuretic Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical marke...
November 2025
119 pages
Intersectional Neurodiversity Market Forecasts to 2032 – Global Analysis By Neurodivergent Condition (Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), Dyslexia and Learning Disabilities, Tourette Syndrome, Sensory Processing Disorder and Other Conditions), Component, Deployment Mode, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Intersectional Neurodiversity Market is accounted for $135.3 million in 2025 and is expected to reach $314.5 million by 2032 growing at a CAGR of 12.8% during...
November 2025
200 pages
Non-Pharmacologic Modulators Market Forecasts to 2032 – Global Analysis By Modality (Cognitive Behavioral Therapy (CBT), Mindfulness-Based Stress Reduction (MBSR), Biofeedback, Neurofeedback, Transcranial Magnetic Stimulation (TMS) and Other Modalities), Mechanism of Action, Delivery Mode, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Non-Pharmacologic Modulators Market is accounted for $1.78 billion in 2025 and is expected to reach $2.55 billion by 2032 growing at a CAGR of 5.2% during the...
November 2025
200 pages
Pharma Hub And Patient Access Support Service Market Size, Share & Trends Analysis Report By Service Type (Program Enrollment, Treatment Navigators, Reimbursement Services/Affordability Services, Clinical Educator), By Service Delivery Type, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global pharma hub and patient access support service market size was estimated at USD 3.24 billion in 2024 and is projected to reach USD 7.63 billion by 2033, growing at a CAGR of 10.0% from 2025...
November 2025
100 pages
U.S. Urinary Incontinence Therapeutics Market Size, Share & Trends Analysis Report By Type (Stress Incontinence, Urge Incontinence), By Drug Class, By Gender, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. urinary incontinence therapeutics market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 2.41 billion by 2033, growing at a CAGR of 5.06% from 2025 to 2033. The U...
November 2025
150 pages
Asia Pacific Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific bacterial vaginosis (BV) drug market is projected to experience significant growth, with an expected market size of approximately US$ 691.1 million by 2031, up from US$ 380.6 million...
November 2025
167 pages
Asia Pacific Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Asia Pacific Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 508.7 billion by 2031, up from US$ 304.0 billion in 2024. This growth represents a compound ann...
November 2025
230 pages
Europe Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 1,060.6 million by 2031, up from US$ 607.2 million in 2024. This growth represents a compo...
November 2025
165 pages
Europe Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Europe Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 537.6 billion by 2031, up from US$ 335.0 billion in 2024, reflecting a compound annual growth rate (C...
November 2025
225 pages
Middle East & Africa Bacterial Vaginosis Drug Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription Drugs and Over-the-Counter Drugs), Route of Administration (Oral, Topical, and Vaginal), Dosage Form (Creams, Gels, Pills, Solutions/Washes, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East and Africa Bacterial Vaginosis (BV) Drug Market is projected to grow significantly, reaching an estimated US$ 150.5 million by 2031, up from US$ 89.7 million in 2024. This growth repre...
November 2025
156 pages
Middle East & Africa Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
US$ 3,450.00
The Middle East & Africa (MEA) Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 64.4 billion by 2031, up from US$ 41.7 billion in 2024. This growth represents a...
November 2025
218 pages
